Viracta TherapeuticsVIRX
13F holders, Q1 2024 (March 31)40holders
2famous investors
$1.02avg. 13F price*
At the end of Q1 2024, 40 institutions reported holding Viracta Therapeutics Inc. (VIRX) in their 13F filings. The largest holders were BVF Inc. ($3.7M), Citadel Advisors ($1.6M) and Vanguard Group Inc. ($1.2M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Viracta Therapeutics Inc.
- CUSIP
- 92765F108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $34K |
| Exits | 6 | $73K |
Ownership 40 holders
| BVF Inc. | 0.10% | No change | 3,614,662 | $3.7M |
| Citadel Advisors | 0.00% | Add +2.4% | 1,565,202 | $1.6M |
| Vanguard Group Inc. | 0.00% | No change | 1,161,280 | $1.2M |
| Samsara Biocapital, LLC | 0.11% | No change | 689,709 | $704K |
| Laurion Capital Management LP | 0.01% | Reduce -25.3% | 420,426 | $429K |
| MAI Capital Management | 0.00% | Add +2.4% | 364,097 | $371K |
| BlackRock Inc. | 0.00% | Reduce -0.6% | 303,980 | $310K |
| Aisling Capital Management LP | 0.10% | No change | 288,571 | $294K |
| Geode Capital Management, LLC | 0.00% | No change | 252,701 | $258K |
| Renaissance Technologies | 0.00% | Add +13.2% | 202,499 | $207K |
| Morgan Stanley | 0.00% | Add +35.1% | 118,016 | $120K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 74,000 | $75K |
| State Street Corp. | 0.00% | No change | 65,867 | $67K |
| Ensign Peak Advisors, Inc | 0.00% | No change | 63,406 | $65K |
| Northern Trust Corp. | 0.00% | Add +4.7% | 38,190 | $39K |
| United Bank | 0.00% | No change | 25,200 | $26K |
| Beacon Pointe Advisors, LLC | 0.00% | New | 17,500 | $18K |
| XTX Topco Ltd | 0.00% | Add +44.6% | 16,988 | $17K |
| Inspirion Wealth Advisors, LLC | 0.00% | Add +50.0% | 15,000 | $15K |
| Hoylecohen, LLC | 0.00% | No change | 14,000 | $14K |
| Trust Co. of Toledo NA | 0.00% | No change | 12,317 | $13K |
| Bank of America Corp. | 0.00% | Add +52.2% | 12,271 | $13K |
| WealthTrust Axiom LLC | 0.00% | New | 11,396 | $12K |
| Acadian Asset Management LLC | 0.00% | Reduce -83.1% | 10,908 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -36.5% | 8,889 | $9K |
| Planning Capital Management Corp | 0.01% | No change | 7,272 | $7K |
| Simplex Trading, LLC | 0.00% | New | 4,884 | $4K |
| RP Management, LLC | 0.00% | No change | 3,700 | $4K |
| IAG Wealth Partners, LLC | 0.00% | No change | 3,000 | $3K |
| Barclays PLC | 0.00% | No change | 2,668 | $3K |
| Royal Bank of Canada | 0.00% | Reduce -80.3% | 2,068 | $2K |
| Lanark Financial, Inc. | 0.00% | New | 1,400 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 721 | $735 |
| Wells Fargo & Company | 0.00% | Add +0.8% | 385 | $392 |
| Indiana Trust & Investment Management Co | 0.00% | No change | 200 | $204 |
| UBS Group AG | 0.00% | Reduce -99.9% | 95 | $97 |
| NewEdge Advisors, LLC | 0.00% | No change | 14 | $14 |
| Parallel Advisors, LLC | 0.00% | No change | 8 | $8 |
| Addison Advisors LLC | 0.00% | No change | 4 | $5 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $2 |
"% of holder's portfolio" is VIRX's weight in each manager's 13F, not the share of Viracta Therapeutics Inc. the manager owns.